A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT02533401 · COMPLETED

Trial details

NCT number: NCT02533401
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphocytic Leukemia, Chronic

Start date: 2006-02-01
Primary completion: 2014-12-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.